These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24871995)

  • 21. Understanding the Molecular Basis of 5-HT
    Castro-Alvarez A; Chávez-Ángel E; Nelson R
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic modulators of the serotonin 5-HT
    Lanthier C; Dallemagne P; Lecoutey C; Claeysen S; Rochais C
    Expert Opin Ther Pat; 2020 Jul; 30(7):495-508. PubMed ID: 32400221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic activation of 5-HT4 receptors or blockade of 5-HT6 receptors improve memory performances.
    Quiedeville A; Boulouard M; Hamidouche K; Da Silva Costa-Aze V; Nee G; Rochais C; Dallemagne P; Fabis F; Freret T; Bouet V
    Behav Brain Res; 2015 Oct; 293():10-7. PubMed ID: 26187692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
    Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
    J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and pharmacological properties of a new hydrophilic and orally bioavailable 5-HT4 antagonist.
    Brudeli B; Moltzau LR; Nguyen CH; Andressen KW; Nilsen NO; Levy FO; Klaveness J
    Eur J Med Chem; 2013 Jun; 64():629-37. PubMed ID: 23711770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment.
    Shen F; Smith JA; Chang R; Bourdet DL; Tsuruda PR; Obedencio GP; Beattie DT
    Neuropharmacology; 2011; 61(1-2):69-79. PubMed ID: 21392515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of 5-HT4R ligands: state of art and clinical applications.
    Bureau R; Boulouard M; Dauphin F; Lezoualc'h F; Rault S
    Curr Top Med Chem; 2010; 10(5):527-53. PubMed ID: 20166943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin 4 receptor (5-HT4R) internalization is isoform-specific: effects of 5-HT and RS67333 on isoforms A and B.
    Mnie-Filali O; Amraei MG; Benmbarek S; Archer-Lahlou E; Peñas-Cazorla R; Vilaró MT; Boye SM; Piñeyro G
    Cell Signal; 2010 Mar; 22(3):501-9. PubMed ID: 19922792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of a serotonin 4 receptor radiotracer with decreased lipophilicity for single photon emission computed tomography.
    Fresneau N; Dumas N; Tournier BB; Fossey C; Ballandonne C; Lesnard A; Millet P; Charnay Y; Cailly T; Bouillon JP; Fabis F
    Eur J Med Chem; 2015 Apr; 94():386-96. PubMed ID: 25778994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749.
    Long DD; Armstrong SR; Beattie DT; Choi SK; Fatheree PR; Gendron RA; Goldblum AA; Humphrey PP; Marquess DG; Shaw JP; Smith JA; Derek Turner S; Vickery RG
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4849-53. PubMed ID: 22683222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New sorting nexin (SNX27) and NHERF specifically interact with the 5-HT4a receptor splice variant: roles in receptor targeting.
    Joubert L; Hanson B; Barthet G; Sebben M; Claeysen S; Hong W; Marin P; Dumuis A; Bockaert J
    J Cell Sci; 2004 Oct; 117(Pt 22):5367-79. PubMed ID: 15466885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for Serotonin Receptor 4 Agonists Using a GPCR-Based Sensor in Yeast.
    Yasi EA; Peralta-Yahya P
    Methods Mol Biol; 2021; 2268():77-84. PubMed ID: 34085262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vivo rat striatal 5-HT4 receptor occupancy using non-radiolabelled SB207145.
    Nirogi R; Kandikere V; Bhyrapuneni G; Saralaya R; Ajjala DR; Aleti RR; Rasheed MA
    J Pharm Pharmacol; 2013 May; 65(5):704-12. PubMed ID: 23600388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon.
    Irving HR; Tan YY; Tochon-Danguy N; Liu H; Chetty N; Desmond PV; Pouton CW; Coupar IM
    Life Sci; 2007 Mar; 80(13):1198-205. PubMed ID: 17258778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SSP-002392, a new 5-HT4 receptor agonist, dose-dependently reverses scopolamine-induced learning and memory impairments in C57Bl/6 mice.
    Lo AC; De Maeyer JH; Vermaercke B; Callaerts-Vegh Z; Schuurkes JA; D'Hooge R
    Neuropharmacology; 2014 Oct; 85():178-89. PubMed ID: 24863046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the 5-HT
    Nedi T; White PJ; Coupar IM; Irving HR
    BMC Res Notes; 2018 Jun; 11(1):362. PubMed ID: 29884229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and binding properties of novel and selective 5-HT3 and 5-HT4 receptor ligands.
    Modica M; Santagati M; Guccione S; Russo F; Cagnotto A; Goegan M; Mennini T
    Eur J Med Chem; 2001 Mar; 36(3):287-301. PubMed ID: 11337106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of tripeptides for lead discovery of 5-HT4 receptor ligands.
    Hanna-Elias A; Thompson PE; Manallack DT; Irving HR; Coupar IM; Berque-Bestel I; Iskander MN
    Protein Pept Lett; 2009; 16(7):805-9. PubMed ID: 19601910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of multiple 5-HT₄ partial agonist clinical candidates for the treatment of Alzheimer's disease.
    Brodney MA; Johnson DE; Sawant-Basak A; Coffman KJ; Drummond EM; Hudson EL; Fisher KE; Noguchi H; Waizumi N; McDowell LL; Papanikolaou A; Pettersen BA; Schmidt AW; Tseng E; Stutzman-Engwall K; Rubitski DM; Vanase-Frawley MA; Grimwood S
    J Med Chem; 2012 Nov; 55(21):9240-54. PubMed ID: 22974325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.
    Cappelli A; Anzini M; Vomero S; Canullo L; Mennuni L; Makovec F; Doucet E; Hamon M; Menziani MC; De Benedetti PG; Bruni G; Romeo MR; Giorgi G; Donati A
    J Med Chem; 1999 May; 42(9):1556-75. PubMed ID: 10229626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.